Name: 5th International Cannabinoid-Derived Pharmaceuticals Summit
Start: 2022-09-06T00:00:00-04:00
End: 2022-09-08T23:59:59-04:00
Location: Westin Boston Seaport District

FDA’s Draft Guidance for Clinical Research Regarding Cannabis and Cannabis Derivatives Takes a Firm Stance on the 0.3% THC Level

August 25, 2020
Agustin Rodriguez
Hemp Policy & Legal
0 Comments

By Agustin Rodriguez and Dascher Pasco On Tuesday, July 21, 2020, the U.S. Food and Drug Administration (FDA) issued “Cannabis and Cannabis-Derived Compounds: Quality Considerations for Clinical Research, Draft Guidance for Industry.” This is the first draft guidance from the…